Zobrazeno 1 - 10
of 31
pro vyhledávání: '"José A. Gómez-Vidal"'
Autor:
Victoriano Corpas-López, Victoriano Díaz-Sáez, Francisco Morillas-Márquez, Francisco Franco-Montalbán, Mónica Díaz-Gavilán, Julián López-Viota, Margarita López-Viota, José Antonio Gómez-Vidal, Joaquina Martín-Sánchez
Publikováno v:
Animals, Vol 12, Iss 19, p 2700 (2022)
Canine leishmaniosis is a challenge in veterinary medicine and no drug to date has achieved parasite clearance in dogs. Histone deacetylase inhibitors are a drug class widely used in cancer chemotherapy. We have successfully used O-alkyl hydroxamates
Externí odkaz:
https://doaj.org/article/e2e7a3f31bac45138ed58707bc3b46bf
Autor:
Yudibeth Sixto-López, Cynthia Ordaz-Pichardo, José Antonio Gómez-Vidal, Martha Cecilia Rosales-Hernández, José Correa-Basurto
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 396:1211-1222
Autor:
David Méndez-Luna, Loreley Araceli Morelos-Garnica, Juan Benjamín García-Vázquez, Martiniano Bello, Itzia Irene Padilla-Martínez, Manuel Jonathan Fragoso-Vázquez, Alfonso Dueñas González, Nuria De Pedro, José Antonio Gómez-Vidal, Humberto Lubriel Mendoza-Figueroa, José Correa-Basurto
Publikováno v:
Pharmaceuticals, Vol 14, Iss 1, p 49 (2021)
The implementation of chemo- and bioinformatics tools is a crucial step in the design of structure-based drugs, enabling the identification of more specific and effective molecules against cancer without side effects. In this study, three new compoun
Externí odkaz:
https://doaj.org/article/adf3f9207ef946e0acee2c9d6a74b139
Autor:
Victoriano, Corpas-López, Victoriano, Díaz-Sáez, Francisco, Morillas-Márquez, Francisco, Franco-Montalbán, Mónica, Díaz-Gavilán, Julián, López-Viota, Margarita, López-Viota, José Antonio, Gómez-Vidal, Joaquina, Martín-Sánchez
Publikováno v:
Animals : an open access journal from MDPI. 12(19)
Canine leishmaniosis is a challenge in veterinary medicine and no drug to date has achieved parasite clearance in dogs. Histone deacetylase inhibitors are a drug class widely used in cancer chemotherapy. We have successfully used
Autor:
Manuel Jonathan Fragoso-Vázquez, José A. Gómez-Vidal, Emilie Marhuenda, Bakalara Norbert, Yudibeth Sixto-López, Martha Cecilia Rosales-Hernández, José Correa-Basurto, Juan Benjamín García-Vázquez, David Cornu, Oscar J. Zacarías‐Lara, David Méndez-Luna
Publikováno v:
Cellular and Molecular Neurobiology. 42:1909-1920
Glioblastoma multiforme (GBM) is account for 70% of all primary malignancies of the central nervous system. Median The survival of human patients after treatment is around 15 months. There are However, several biological targets which have been repor
Autor:
Yudibeth Sixto-López, Margarita López-Viota, Sonia Panadero-Fajardo, Mavys Tabraue-Chávez, Mónica Díaz-Gavilán, José Pérez del Palacio, José Correa-Basurto, Joaquina Martín-Sánchez, Mercedes de la Cruz, Fernando Alves de Lima Franco, Nuria de Pedro, José F. Domínguez-Seglar, Victoriano Corpas-López, Francisco Franco-Montalban, Francisco Morillas-Márquez, Julian Lopez-Viota, José A. Gómez-Vidal
Publikováno v:
Journal of Medicinal Chemistry. 63:5734-5751
Leishmania (L.) infantum causes visceral, cutaneous, and mucosal leishmaniasis in humans and canine leishmaniasis in dogs. Herein, we describe that O-alkyl hydroxamate derivatives displayed potent and selective in vitro activity against the amastigot
Autor:
Yudibeth Sixto-Lopez, José Correa-Basurto, Martiniano Bello, José A. Gómez-Vidal, Martha Cecilia Rosales-Hernández, Nuria de Pedro
Publikováno v:
Journal of biomolecular structuredynamics. 40(24)
HDAC6 has emerged as a molecular target to treat neurodegenerative disorders, due to its participation in protein aggregate degradation, oxidative stress process, mitochondrial transport, and axonal transport. Thus, in this work we have designed a se
Autor:
Margarita López-Viota, Francisco Morillas-Márquez, Victoriano Corpas-López, Joaquina Martín-Sánchez, José Pérez del Palacio, Nuria de Pedro, Efres Belmonte-Reche, José A. Gómez-Vidal, Julián López-Viota, Mónica Díaz-Gavilán, Gemma Merino-Espinosa, Francisco Franco-Montalban
Publikováno v:
Pharmacological Research. 139:375-383
There is currently no satisfactory treatment for visceral leishmaniasis; the disease is thus in desperate need of novel drugs. The ideal candidate should be effective, safe, affordable, and administered via the oral route. Histone deacetylases (HDACs
Autor:
José A. Gómez-Vidal, Maria Dolores Moya-Garzon, Joaquín Altarejos, Alfonso Alejo-Armijo, Sofía Salido, Miguel X. Fernandes, Mónica Díaz-Gavilán, Juan R. Rodriguez-Madoz, Eduardo Salido
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 74, p 74 (2021)
Journal of Personalized Medicine, Vol 11, Iss 74, p 74 (2021)
Primary hyperoxalurias (PHs) are a group of inherited alterations of the hepatic glyoxylate metabolism. PHs classification based on gene mutations parallel a variety of enzymatic defects, and all involve the harmful accumulation of calcium oxalate cr
Autor:
José A. Gómez-Vidal, Yudibeth Sixto-López, Martha Cecilia Rosales-Hernández, Nuria de Pedro, José Correa-Basurto, Martiniano Bello
Publikováno v:
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Scientific Reports, Vol 10, Iss 1, Pp 1-17 (2020)
Scientific Reports
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Scientific Reports, Vol 10, Iss 1, Pp 1-17 (2020)
Scientific Reports
Histone deacetylases (HDACs) belong to a family of enzymes that remove acetyl groups from the ɛ-amino of histone and nonhistone proteins. Additionally, HDACs participate in the genesis and development of cancer diseases as promising therapeutic targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0d31bdd23a713bf819c41943fd7a6cf
http://hdl.handle.net/10481/63205
http://hdl.handle.net/10481/63205